This translation has been automatically generated and has not been verified for accuracy.A U.S. recommendation that consumers avoid vaping products containing the active ingredient in marijuana could be a blow to Canadian cannabis companies’ hopes that the higher-margin products will help propel them to profitability.
The Horizons Marijuana Life Sciences Index ETF has dropped 54% since its Oct. 16 peak, the day before adult recreational use of cannabis flower and THC and CBD oils were legalized. CBD does not contain the compound that gets people high. Analysts estimate that in some established U.S. markets, vape sales are down as much as 30%, with many marijuana consumers reverting to use of less profitable flower and oil products.
“In theory, it should promote the legal market,” Zandberg said. “But if you don’t have very aggressive education behind these products, a good portion of the population doesn’t see the difference.” “The Canadian government should come out as soon as possible one way or other and either double down on vape products or remove them from the derivatives market. You have to give the industry clarity,” said Brett Hundley, a cannabis analyst at Seaport Global.
Why do we always have to wait for the U.S. find out all this crap? What does Health Canada do anyway?
Greed & lack of investigation into product sourcing & safety impacts THC vaping products. Research. It’s important.
Blame government for screwing up this industry!